Artículo original 15 de agosto de 2026

PET/TC con 13N-amonio y 18F-FDG en el diagnóstico y monitoreo del tratamiento de la sarcoidosis cardíaca

Referenciar Imprimir

Referencias

  1. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009;120:1969–77.
  2. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease. Eur Heart J. 2007;28:3076–93.
  3. Campisi R, Merani MF, Marina MI. BMIPP SPECT in cardiac sarcoidosis: A marker of risk? J Nucl Cardiol 2021;28:930–5.
  4. Diagnostic standard and guidelines for sarcoidosis. Japanese J Sarcoidosis Granulomatous Disord. 2007;27:89-102.
  5. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23.
  6. Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014;63:329–36.
  7. Bravo PE, Raghu G, Rosenthal DG, et al. Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging. Int J Cardiol 2017; 241:457.
  8. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003; 44:1030–6.
  9. Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012; 53:241.
  10. Campisi R, Merani MF, Rodriguez MI. Current Cardiology Reports, 2022, 24(12):1873-1882. https://doi.org/10.1007/s11886-022-01803-4
  11. Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/TC in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol 2017; 24:1741.
  12. Wiefels C, Boczar K, Birnie D, et al. Quantification of metabolic activity in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2025;43:102088.
  13. Ahmadian A, Brogran A, Berman J, et al. Quantitative interpretation of FDG PET/TC with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2014;21:925–39.
  14. Vita T, Okada DR, Veillet-Chowdhury M, et al. Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging 2018; 11:e007030.
  15. Slart RHJA, Glaudemans AWJM, Lancellotti P, et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. J Nucl Cardiol 2018;25:298–319.
  16. Bravo P, Taqueti V. Cardiac MRI vs. PET for the evaluation of cardiac sarcoidosis: Consider MRI first. J Am Coll of Cardiol 2017; Expert analysis.
  17. Ahluwalia M, Pan S, Ghesani M, Phillips LM. A new era of imaging for diagnosis and management of cardiac sarcoidosis: Hybrid cardiac magnetic resonance imaging and positron emission tomography. J Nucl Cardiol 2019;26:1996-2004.
  18. Tilkemeier PL, Bourque J, Doukky R, et al. ASNC imaging guidelines for nuclear cardiology procedures: Standardized reporting of nuclear cardiology procedures. J Nucl Cardiol 2017;24:2064-128.
  19. Bokhari S, Lin JC, Julien HM. FDG is a superior tool in the diagnosis and management of cardiac sarcoidosis. Expert analysis. J Am Coll of Cardiol April 10, 2017. https://www.acc.org/latest-in-cardiology/articles/2017/04/10/08/43/fdg-pet-is-a-superior-tool
  20. Bois JP, Muser D, Chareonthaitawee P. PET/TC evaluation of cardiac sarcoidosis. PET Clin 2019;14:223-32.
  21. Treglia G, Taralli S, Mattoli MV, Giordano A. Utility of whole-body Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with sarcoidosis. In: Medical Imaging: Procedures, Techniques and Applications, 2012. p.39-50.
  22. Youssef G, Beanlands RS, Birnie DH, Nery PB. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart 2011; 97:2078.